Damora Therapeutics, Inc. - Ordinary Shares financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 10/08/2026 | Mar 2026Filed 12/05/2026 | Sep 2025Filed 06/11/2025 | Jun 2025Filed 10/08/2026 | Mar 2025Filed 12/05/2026 | Sep 2024Filed 06/11/2025 | Jun 2024Filed 05/08/2025 | Mar 2024Filed 08/05/2025 |
|---|---|---|---|---|---|---|---|---|
| −$31 | −$28 | −$3.1 | −$3.4 | −$2.5 | −$3.9 | −$5.3 | −$5.5 | |
| −$0.39 | −$0.62 | −$2.36 | −$2.60 | −$1.92 | −$3.39 | −$4.92 | −$5.05 | |
| 61 | 34 | 1.3 | 1.3 | 1.3 | 1.1 | — | — |
Trend